DRD1 and Anxiety: As may be expected from the effects of the agonist-stimulation of D1R-D2R heterocomplexes in MDD in female rats (see above), anxiety behavior was more prominent in them than in males and was also ameliorated by the disrupting effects of the TAT-D1 peptide administration [173].